Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
APOGEE ENTERPRISES, INC.
SIC 3231 · Glass Products, Made Of Purchased Glass
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
APOGEE ENTERPRISES, INC.
SIC 3231 · Glass Products, Made Of Purchased Glass
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
APOGEE ENTERPRISES, INC.
SIC 3231 · Glass Products, Made Of Purchased Glass
Support
about
terms
$
APOG
APOGEE ENTERPRISES, INC.
CIK:
0000006845
|
SEC Filings
Cash Flow
Balance Sheet
v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Aug. 29, 2026
Aug. 30, 2025
Operating Activities
Net earnings
$ 33,917
$ 20,962
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization
26,569
24,943
Share-based compensation
4,927
2,773
Deferred income taxes
3,494
17,214
Impairment of long-lived assets
0
7,418
Settlement of New Markets Tax Credit transaction
0
(4,597)
Non-cash lease expense
6,064
5,474
Other, net
4,137
4,129
Changes in operating assets and liabilities:
Receivables
4,666
(9,204)
Inventories
(9,931)
(9,735)
Contract assets
(9,379)
10,518
Accounts payable
(15,576)
(2,575)
Accrued compensation and benefits
2,971
(9,681)
Contract liabilities
(1,621)
15,734
Operating lease liability
(6,952)
(4,608)
Accrued income taxes
2,426
(11,008)
Other current assets and liabilities
(2,453)
(20,477)
Net cash provided by operating activities
43,259
37,280
Investing Activities
Capital expenditures
(17,796)
(11,827)
Purchases of marketable securities
(7,418)
(200)
Acquisition of business, net of cash acquired
(99,574)
0
Other, net
2,957
1,144
Net cash used in investing activities
(121,831)
(10,883)
Financing Activities
Proceeds from revolving credit facilities
161,000
76,000
Repayment on revolving credit facilities
(54,867)
(91,000)
Repayment of term loans
(2,867)
0
Repurchase of common stock
(16,099)
0
Dividends paid
(11,175)
(11,043)
Other, net
(1,117)
(3,087)
Net cash provided by (used in) financing activities
74,875
(29,130)
Effect of exchange rates on cash
702
811
Decrease in cash and cash equivalents
(2,994)
(1,922)
Cash and cash equivalents at beginning of period
39,523
41,448
Cash and cash equivalents at end of period
36,529
39,526
Non-cash Activity
Capital expenditures in accounts payable
$ 1,348
$ 2,202
v3.26.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Aug. 29, 2026
Feb. 28, 2026
Current assets
Cash and cash equivalents
$ 36,529
$ 39,523
Receivables, net
206,327
198,516
Inventories, net
116,760
98,059
Contract assets
68,806
59,512
Other current assets
43,888
43,823
Total current assets
472,310
439,433
Property, plant and equipment, net
277,349
255,032
Operating lease right-of-use assets
42,534
48,736
Goodwill
255,499
236,744
Intangible assets, net
154,383
111,261
Other non-current assets
42,029
31,139
Total assets
1,244,104
1,122,345
Current liabilities
Accounts payable
89,423
105,478
Accrued compensation and benefits
45,506
39,667
Contract liabilities
59,343
60,903
Operating lease liabilities
14,618
14,729
Other current liabilities
55,749
46,079
Total current liabilities
264,639
266,856
Long-term debt
335,545
232,279
Non-current operating lease liabilities
32,351
39,375
Non-current self-insurance reserves
26,866
24,914
Other non-current liabilities
61,369
47,127
Commitments and contingent liabilities (Note 6)
Shareholders’ equity
Common stock of $0.33-1/3 par value; authorized 50,000,000 shares; issued and outstanding 20,893,469 and 21,220,350, respectively
6,964
7,073
Additional paid-in capital
160,039
159,085
Retained earnings
386,047
376,438
Accumulated other comprehensive loss
(29,716)
(30,802)
Total shareholders’ equity
523,334
511,794
Total liabilities and shareholders’ equity
$ 1,244,104
$ 1,122,345